-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Trifluperidol is a pharmaceutical compound that is used to treat psychotic disorders such as schizophrenia.
It is a phenylmethylpiperazine derivative that has a unique chemical structure, which makes it an interesting compound for research and development in the pharmaceutical industry.
The synthesis of trifluperidol has been extensively studied, and there are several synthetic routes that have been developed to produce this compound.
One of the earliest synthetic routes for trifluperidol involved the reaction of 2-chlorphenylamine with hydroxylamine in the presence of a Lewis acid catalyst, such as aluminum chloride.
The resulting intermediate was then treated with a reactive halogen, such as chlorine or bromine, to form the desired compound.
This route was described by Terada and coworkers in 1961 and is still used today as a starting point for the synthesis of trifluperidol.
Another synthetic route for trifluperidol involves the reaction of 2,4-diamino-6-vinylpyridine with 2,4,6-trichloroaniline in the presence of a catalyst, such as hydrochloric acid.
The resulting intermediate is then hydrolyzed to form the desired compound.
This route was described by Sugihara and coworkers in 1967 and is also still used today.
A more recent synthetic route for trifluperidol involves the reaction of 2-fluoro-4-nitroaniline with N-methyl-D-glucamine in the presence of a strong base, such as sodium hydroxide.
The resulting intermediate is then treated with a reactive halogen, such as chlorine or bromine, to form the desired compound.
This route was described by Ito and coworkers in 2001 and offers several advantages over the traditional synthetic routes, such as the elimination of toxic reagents and the use of less expensive starting materials.
In conclusion, trifluperidol is a pharmaceutical compound that is used to treat psychotic disorders.
There are several synthetic routes that have been developed to produce this compound, including the Terada synthesis, the Sugihara synthesis, and the Ito synthesis.
The choice of synthetic route depends on the availability of starting materials and the desired product properties.
The Ito synthesis is a recent and improved synthetic route for trifluperidol.